+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Obesity Intervention Devices Market - Global Obesity Intervention Devices Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030

  • PDF Icon

    Report

  • 245 Pages
  • September 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5887175

Global Obesity Intervention Devices Market Poised to Reach Nearly $0.5 Billion by 2030

The global obesity intervention devices market is on an upward trajectory, with a forecasted valuation of close to $0.5 billion by the year 2030, according to a recent market analysis. The report reveals a robust Compound Annual Growth Rate (CAGR) of 6% expected between 2023 and 2030.

Combatting the Obesity Epidemic

Obesity is a growing global concern, with the prevalence of obesity-related health issues on the rise. Conditions such as cardiovascular disease, type 2 diabetes, and musculoskeletal problems are becoming alarmingly common. This has spurred the demand for effective interventions to address and manage obesity, giving rise to the obesity intervention devices market.

Key Findings

The report highlights several key findings:

  • Rising Obesity Rates Worldwide: The global prevalence of obesity is increasing, with projections indicating that by 2030, one billion people worldwide will grapple with obesity. This underscores the need for innovative solutions to combat this public health crisis.
  • Reducing Healthcare Costs: Obesity-related conditions often lead to costly medical interventions, hospitalizations, and ongoing medication. Obesity intervention devices have the potential to reduce these costs by preventing or managing chronic diseases associated with obesity.
  • Preference for Space-occupying Devices: Gastric balloons, which create a sense of fullness in the stomach, are in high demand. They offer a non-surgical approach to weight loss, making them appealing to individuals hesitant about surgery.
  • Hospitals and Clinics Lead Adoption: Hospitals play a pivotal role in adopting and utilizing obesity intervention devices due to their advanced medical facilities, multidisciplinary approach to obesity management, and specialized healthcare professionals.
  • North America Dominates: North America, particularly the United States, leads the market, driven by a long-standing obesity epidemic, advanced healthcare infrastructure, and regulatory frameworks that encourage innovation.
  • Asia Pacific Presents Growth Potential: Asia Pacific is emerging as a lucrative market due to rapid urbanization, changing lifestyles, and increased awareness of obesity-related health risks.

Market Players

Leading companies in the obesity intervention devices market include Medtronic plc, ReShape Lifesciences, Inc., Cousin Surgery, BAROnova, Inc., A.M.I. GmbH, Johnson & Johnson, Spatz FGIA, Inc., Allurion Technologies, Inc., Endalis Laboratoire, GI Dynamics, Inc., Boston Scientific, and Abbvie, Inc.


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Obesity Intervention Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Obesity Intervention Devices Market Outlook, 2018 - 2030
3.1. Global Obesity Intervention Devices Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Gastric Banding
3.1.1.2. Gastric Space Occupying Devices
3.1.1.3. Gastric Stimulation Systems
3.1.1.4. Gastric Emptying Systems
3.1.1.5. Misc.
3.2. Global Obesity Intervention Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Hospitals & Clinics
3.2.1.2. Obesity Centers
3.2.1.3. Homecare Settings
3.2.1.4. Misc.
3.3. Global Obesity Intervention Devices Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Obesity Intervention Devices Market Outlook, 2018 - 2030
4.1. North America Obesity Intervention Devices Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Gastric Banding
4.1.1.2. Gastric Space Occupying Devices
4.1.1.3. Gastric Stimulation Systems
4.1.1.4. Gastric Emptying Systems
4.1.1.5. Misc.
4.2. North America Obesity Intervention Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Hospitals & Clinics
4.2.1.2. Obesity Centers
4.2.1.3. Homecare Settings
4.2.1.4. Misc.
4.2.2. Market Attractiveness Analysis
4.3. North America Obesity Intervention Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. U.S. Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
4.3.1.2. U.S. Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
4.3.1.3. Canada Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
4.3.1.4. Canada Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Obesity Intervention Devices Market Outlook, 2018 - 2030
5.1. Europe Obesity Intervention Devices Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Gastric Banding
5.1.1.2. Gastric Space Occupying Devices
5.1.1.3. Gastric Stimulation Systems
5.1.1.4. Gastric Emptying Systems
5.1.1.5. Misc.
5.2. Europe Obesity Intervention Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Hospitals & Clinics
5.2.1.2. Obesity Centers
5.2.1.3. Homecare Settings
5.2.1.4. Misc.
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Obesity Intervention Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Germany Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
5.3.1.2. Germany Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
5.3.1.3. U.K. Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
5.3.1.4. U.K. Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
5.3.1.5. France Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
5.3.1.6. France Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
5.3.1.7. Italy Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
5.3.1.8. Italy Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
5.3.1.9. Turkey Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
5.3.1.10. Turkey Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
5.3.1.11. Russia Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
5.3.1.12. Russia Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
5.3.1.13. Rest of Europe Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
5.3.1.14. Rest of Europe Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Obesity Intervention Devices Market Outlook, 2018 - 2030
6.1. Asia Pacific Obesity Intervention Devices Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Gastric Banding
6.1.1.2. Gastric Space Occupying Devices
6.1.1.3. Gastric Stimulation Systems
6.1.1.4. Gastric Emptying Systems
6.1.1.5. Misc.
6.2. Asia Pacific Obesity Intervention Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Hospitals & Clinics
6.2.1.2. Obesity Centers
6.2.1.3. Homecare Settings
6.2.1.4. Misc.
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Obesity Intervention Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. China Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
6.3.1.2. China Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
6.3.1.3. Japan Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
6.3.1.4. Japan Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
6.3.1.5. South Korea Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
6.3.1.6. South Korea Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
6.3.1.7. India Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
6.3.1.8. India Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
6.3.1.9. Southeast Asia Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
6.3.1.10. Southeast Asia Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
6.3.1.11. Rest of Asia Pacific Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
6.3.1.12. Rest of Asia Pacific Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Obesity Intervention Devices Market Outlook, 2018 - 2030
7.1. Latin America Obesity Intervention Devices Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Gastric Banding
7.1.1.2. Gastric Space Occupying Devices
7.1.1.3. Gastric Stimulation Systems
7.1.1.4. Gastric Emptying Systems
7.1.1.5. Misc.
7.2. Latin America Obesity Intervention Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
7.2.1.1. Hospitals & Clinics
7.2.1.2. Obesity Centers
7.2.1.3. Homecare Settings
7.2.1.4. Misc.
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Obesity Intervention Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Brazil Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
7.3.1.2. Brazil Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
7.3.1.3. Mexico Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
7.3.1.4. Mexico Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
7.3.1.5. Argentina Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
7.3.1.6. Argentina Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
7.3.1.7. Rest of Latin America Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
7.3.1.8. Rest of Latin America Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Obesity Intervention Devices Market Outlook, 2018 - 2030
8.1. Middle East & Africa Obesity Intervention Devices Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Gastric Banding
8.1.1.2. Gastric Space Occupying Devices
8.1.1.3. Gastric Stimulation Systems
8.1.1.4. Gastric Emptying Systems
8.1.1.5. Misc.
8.2. Middle East & Africa Obesity Intervention Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Hospitals & Clinics
8.2.1.2. Obesity Centers
8.2.1.3. Homecare Settings
8.2.1.4. Misc.
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Obesity Intervention Devices Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. GCC Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
8.3.1.2. GCC Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
8.3.1.3. South Africa Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
8.3.1.4. South Africa Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
8.3.1.5. Egypt Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
8.3.1.6. Egypt Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
8.3.1.7. Nigeria Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
8.3.1.8. Nigeria Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
8.3.1.9. Rest of Middle East & Africa Obesity Intervention Devices Market by Product, Value (US$ Bn), 2018 - 2030
8.3.1.10. Rest of Middle East & Africa Obesity Intervention Devices Market End User, Value (US$ Bn), 2018 - 2030
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs Product Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. ReShape Lifesciences Inc
9.4.1.1. Company Overview
9.4.1.2. Device Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Cousin Surgery
9.4.2.1. Company Overview
9.4.2.2. Device Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. A.M.I. GmbH
9.4.3.1. Company Overview
9.4.3.2. Device Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Johnson & Johnson
9.4.4.1. Company Overview
9.4.4.2. Device Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Spatz FGIA Inc
9.4.5.1. Company Overview
9.4.5.2. Device Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Allurion Technologies Inc.
9.4.6.1. Company Overview
9.4.6.2. Device Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Endalis Laboratoire
9.4.7.1. Company Overview
9.4.7.2. Device Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. GI Dynamics, Inc.
9.4.8.1. Company Overview
9.4.8.2. Device Portfolio
9.4.8.3. Business Strategies and Development
9.4.9. Apollo Endosurgery
9.4.9.1. Company Overview
9.4.9.2. Device Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Abbvie, Inc.
9.4.10.1. Company Overview
9.4.10.2. Device Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic plc
  • ReShape Lifesciences, Inc.
  • Cousin Surgery
  • A.M.I. GmbH
  • BAROnova, Inc.
  • Johnson & Johnson
  • Allurion Technologies, Inc.
  • Endalis Laboratoire
  • GI Dynamics
  • Boston Scientific
  • Abbvie Inc.
  • Spatz FGIA Inc

Methodology

Loading
LOADING...